LP-001, a Novel Long-Acting EPO-Fc Fusion Protein: A Phase I Dose-Escalation Study of Pharmacokinetics, Safety, and Tolerability in Healthy Chinese Subjects
{{output}}
The objective of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of LP-001 injection in healthy Chinese subjects. This was a single-center, double-blind, randomized, dose-escalation study. Fifty-six healthy adults were enrolled and... ...
